NYSE:ELVHealthcare
A Look At Elevance Health (ELV) Valuation After Earnings Beat And Higher EPS Guidance
Elevance Health (ELV) is back in focus after reporting Q1 revenue and earnings above analyst expectations and lifting full year 2026 adjusted EPS guidance, following higher than expected 2027 Medicare Advantage payment rates.
See our latest analysis for Elevance Health.
The recent earnings beat and higher 2026 EPS guidance have coincided with strong momentum, with Elevance Health’s 90 day share price return of 46.46% and a 1 year total shareholder return of 12.87% suggesting sentiment has...